Overview

Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study in de novo renal transplant patients is to evaluate the effect on renal function of an optimized new regimen in comparison with the standard everolimus exposure plus a low-dose cyclosporine microemulsion regimen.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Cyclosporine
Cyclosporins
Everolimus
Sirolimus